Clearity's Director of Science and Clinical Trials, Anne Mette Buhl, PhD sat down with the first staff member Dr. Laura Shawver brought on board when she started Clearity 15 years ago.
Prior to her retirement last year, Dr. Deb Zajchowski, known to many as Dr Deb, was the main contact for ovarian cancer patients who came to Clearity for guidance on getting their tumors profiled and to better understand the treatment options available to them based on their diagnosis and tumor biology.
Deb’s knowledge about ovarian cancer tumor biology, genetic factors and the treatment landscape is immense. But so is the compassion she has for every single person she has spoken to over the years.
In true Deb fashion, she has kept up on promising research and treatment advancements for ovarian cancer. Hear her thoughts on the future and reasons to remain hopeful.
Негізгі бет Celebrating Dr. Deb
Пікірлер